Back
Apellis Pharmaceuticals Vs. Merus NV Industry Stock Comparison
Buy
59
APLS
Apellis Pharmaceuticals
Last Price:
$24.37
Seasonality Move:
-5.27%
Buy
53
MRUS
Merus NV
Last Price:
$63.36
Seasonality Move:
3.79%
Buy
59
Apellis Pharmaceuticals (APLS)
is a Buy
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
-
The current Apellis Pharmaceuticals [APLS] share price is $23.73. The Score for APLS is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
APLS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $23.73Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing slight buying pressure.
APLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.24 | Buy |
Relative Strength Index (14 RSI): | 70.96 | Buy |
Chaikin Money Flow: | 124979 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (18.15 - 21.93) | Buy |
Bollinger Bands (100): | (17.25 - 21.87) | Buy |
MRUS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 18.1 | Buy |
Relative Strength Index (14 RSI): | 64.17 | Buy |
Chaikin Money Flow: | 1043434 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (55.29 - 66.29) | Buy |
Bollinger Bands (100): | (41.93 - 58.91) | Buy |
APLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 21.77 | Buy |
20-day SMA: | 20.52 | Buy |
50-day SMA: | 19.15 | Buy |
200-day SMA: | 24.6 | Sell |
8-day EMA: | 22.42 | Buy |
20-day EMA: | 20.9 | Buy |
50-day EMA: | 19.9 | Buy |
200-day EMA: | 24.99 | Sell |
MRUS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 66.17 | Sell |
20-day SMA: | 62.66 | Buy |
50-day SMA: | 57.67 | Buy |
200-day SMA: | 47.83 | Buy |
8-day EMA: | 54.89 | Buy |
20-day EMA: | 33.39 | Buy |
50-day EMA: | 16.19 | Buy |
200-day EMA: | 4.48 | Buy |
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.08 per share, a decrease next quarter of $1.11 per share, an increase this year of $1.21 per share, and a decrease next year of $0.63 per share.
Merus NV Earnings Growth & MRUS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.47 per share, and an increase next year of $0.76 per share.
Apellis Pharmaceuticals Technical Analysis
Jul 24 | Jul 25 | Jul 28 | Jul 29 | Jul 30 | Jul 31 | Aug 1 | Aug 4 | Aug 5 | Aug 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | Aug | |||||||||
24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Merus NV Technical Analysis
Jul 24 | Jul 25 | Jul 28 | Jul 29 | Jul 30 | Jul 31 | Aug 1 | Aug 4 | Aug 5 | Aug 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | Aug | |||||||||
24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |